AbbVie Financials

Market Capitalization $301.60 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	59.47
Forward PE	14.07
Price to Sales TTM	$5.43
Price to Book MRQ	$50.01
Enterprise to Revenue	6.59
Enterprise to EBITDA	14.27

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	9.22%
Operating Margin	28.93%
Return on Assets TTM	7.72%
Return on Equity TTM	56.41%

Income Statement

Revenue TTM	$55,532,998,656
Revenue per Share TTM	$31.40
Quarterly Revenue Growth	3.80%
Gross Profit TTM	$39,059,001,344
EBITDA	$19,461,000,000
Net Income to Common TTM	$5,080,999,936
Diluted EPS TTM	$2.87
Quarterly Earnings Growth YoY	-12.20%

Balance Sheet

Total Cash MRQ	$7,285,000,192
Total Cash per Share MRQ	$4.12
Total Debt MRQ	$
Total Debt to Equity MRQ	1174.82
Current Ratio MRQ	0.65
Book Value per Share MRQ	$3.41

Cash Flow

Operating Cash Flow TTM	$16,510,999,552
Levered Free Cash Flow TTM	$17,738,999,808

ABBV Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	1,767,139,968
Float Shares	1,763,994,813
Avg 10 Volume	6,463,800
Avg 30 Volume	None
Shares Short	17,003,576
Short Ratio	2.95
Short % of Shares	0.96%
% Held by Insiders	0.10%
% Held by Institutions	73.51%

Stock Price Summary

Beta	0.61
Fifty Two Week Low	$153.58
Fifty Two Week High	$207.32
Fifty Two Week Change	3.75%
Day 50 MA	$175.61
Day 200 MA	$178.63

Dividends and Splits

Forward Annual Dividend Rate	$6.56
Forward Annual Dividend Yield	3.85%
Trailing Annual Dividend Rate	$6.29
Trailing Annual Dividend Yield	3.69%
Payout Ratio	213.59%
Dividend Date	2025-02-14
Ex Dividend Date	2025-01-15
Last Split Factor
Last Split Date